A Novel Method for Modification of Tumor Cells with Bacterial Superantigen with a Heterobifunctional Cross-Linking Agent in Immunotherapy of Cancer

Author： Shimizu Motomu   Matsuzawa Akio   Takeda Yasutaka  

Publisher： Humana Press, Inc

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.25, Iss.1, 2003-09, pp. : 89-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modification of Tumor Cells with Fas (CD95) Antigen Gene and Fas Ligand (CD95L) Gene Transfection by Electroporation for Immunotherapy of Cancer

By Shimizu Motomu   Yoshimoto Takayuki   Matsuzawa Akio   Takeda Yasutaka  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 79-88

Humana Press, Inc

Access to resources Recommend Favorite

Increased thermal stability of glucose dehydrogenase by cross-linking chemical modification

By Yamazaki T.   Tsugawa W.   Sode K.  

Biotechnology Letters, Vol. 21, Iss. 3, 1999-03 ,pp. : 199-202

Springer Publishing Company

Access to resources Recommend Favorite

Preparation of Peptide-Loaded Dendritic Cells for Cancer Immunotherapy

By Morse Michael A.   Clay Tim   Colling Kirsten   Lyerly H. Kim  

Molecular Biotechnology, Vol. 25, Iss. 1, 2003-09 ,pp. : 95-100

Humana Press, Inc

Access to resources Recommend Favorite

Exploiting dendritic cells for active immunotherapy of cancer and chronic infections

By O’Neill David   Bhardwaj Nina  

Molecular Biotechnology, Vol. 36, Iss. 2, 2007-06 ,pp. : 131-141

Humana Press, Inc

Access to resources Recommend Favorite

Development of an aspartic acid-based cross-linking monomer for improved bioseparations

By Spivak D.A.  

Bioseparation, Vol. 10, Iss. 6, 2001-01 ,pp. : 331-336

Springer Publishing Company

Access to resources Recommend Favorite